Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, September 28, 2023
Evonik is strengthening its platform of parenteral drug delivery solutions with three new standard PLA-PEG di-block copolymers and a new nanoparticle formulation service using sonication technology.
read more
Wednesday, March 04, 2020
Alopexx Oncology has entered into an exclusive license agreement with Beijing Shenogen Pharma Group to develop and commercialize DI-Leu16-IL2 in China and other parts of Asia.
read more
I-Mab announced the appointment of Fernando J. Salle´s, Ph.D., CLP®, as Senior Vice President, Head of U.S. & EU Business Development, effective March 30, 2020.
read more
Virtify, Inc.,a leading innovator in content and regulatory information management solutions for the life science industry, today announced Indiana University has signed an enterprise-level contract for its Clinical Trial Registration & Results (CTRR...
read more
Wednesday, October 14, 2020
Johnson & Johnson announced the EC has approved an Advance Purchase Agreement in which the Janssen will supply 200 million doses of its COVID-19 vaccine candidate to EU Member States following approval or authorization from regulators.
read more
Monday, November 07, 2016
Lonza has opened its pharmaceutical Drug Product Services laboratories in the Stücki Science Park Basel (CH). Scientists in the new 1300 m2 facility will focus initially on formulation development, drug product analytical development and quality ...
read more
Wednesday, November 16, 2022
QPS recently opened a second preclinical research facility in Taipei, Taiwan. The 2,793-square-foot facility will facilitate a research expansion into additional toxicology studies and a newly launched capability in pharmacology studies.
read more
Aptar Pharma, part of AptarGroup, Inc., announced the next phase of its global capacity expansion plan in North America, at its Aptar Congers, New York site.
read more
Tuesday, September 16, 2025
Worldwide Clinical Trials has appointed Alistair Macdonald as Chief Executive Officer, effective immediately. A seasoned executive with decades of leadership and operational experience in the clinical research industry, Macdonald succeeds Peter ...
read more
Wednesday, August 07, 2019
Late last week, a U.S. District Court judge in Washington, D.C. issued a decision that upheld FDA’s interpretation of clinical need regarding the bulk substances that may be used by outsourcing facilities in drug compounding.
read more
Thursday, August 27, 2020
Mapp has contracted Avid to provide process transfer, scale-up and clinical manufacturing services to support one of its development programs for a novel antiviral drug candidate.
read more
Roche (SIX: RO, ROG; OTCQX: RHHBY) and AmorChem L.P., a Montreal-based venture capital firm
investing in life science projects, today announced they have entered into a collaboration to discover
novel small molecule disease-modifying therapy for ...
read more
Friday, November 21, 2014
Sonoco ThermoSafe, a unit of Sonoco (NYSE:SON) and a leading global provider of temperature assurance packaging, has launched a series of shipping solutions for temperature-sensitive products shipped direct-to-patient. The Envoy® Direct Series has ...
read more
The FDA has announced it will inactivate listing records in its database that have not been recently updated or certified or that include an establishment with an expired registration.
read more
Wednesday, March 18, 2020
Asklepios has entered into a research collaboration and licensing agreement with the UNC for the development and commercialization of gene therapy for Angelman syndrome.
read more